SignatureFD’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.6K | Sell |
329
-196
| -37% | -$2.74K | ﹤0.01% | 2622 |
|
|
2025
Q1 | $7.14K | Sell |
525
-78
| -13% | -$1.06K | ﹤0.01% | 2465 |
|
|
2024
Q4 | $12.3K | Buy |
603
+39
| +7% | +$795 | ﹤0.01% | 2289 |
|
|
2024
Q3 | $16.4K | Buy |
564
+30
| +6% | +$874 | ﹤0.01% | 2124 |
|
|
2024
Q2 | $12.4K | Sell |
534
-196
| -27% | -$4.55K | ﹤0.01% | 2176 |
|
|
2024
Q1 | $15K | Sell |
730
-190
| -21% | -$3.9K | ﹤0.01% | 2133 |
|
|
2023
Q4 | $19.7K | Buy |
920
+294
| +47% | +$6.31K | ﹤0.01% | 1928 |
|
|
2023
Q3 | $12.9K | Buy |
626
+300
| +92% | +$6.19K | ﹤0.01% | 2066 |
|
|
2023
Q2 | $9.62K | Buy |
326
+105
| +48% | +$3.1K | ﹤0.01% | 2249 |
|
|
2023
Q1 | $5.09K | Buy |
221
+126
| +133% | +$2.9K | ﹤0.01% | 2497 |
|
|
2022
Q4 | $2.64K | Buy |
95
+55
| +138% | +$1.53K | ﹤0.01% | 2711 |
|
|
2022
Q3 | $1K | Buy |
40
+35
| +700% | +$875 | ﹤0.01% | 2934 |
|
|
2022
Q2 | $0 | Sell |
5
-48
| -91% | – | ﹤0.01% | 3148 |
|
|
2022
Q1 | $2K | Buy |
+53
| New | +$2K | ﹤0.01% | 2781 |
|
|
2021
Q2 | – | Sell |
-67
| Closed | -$4K | – | 2952 |
|
|
2021
Q1 | $4K | Buy |
67
+57
| +570% | +$3.4K | ﹤0.01% | 2217 |
|
|
2020
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 2399 |
|